Biotech

All Articles

Zephyrm looks for Hong Kong IPO to finance period 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, submitting (PDF) for an IPO to ...

Frazier Life Sciences gathers $630M for little, mid-cap biotechs

.Frazier Life Sciences has sourced an even further $630 million for its own fund concentrated on lit...

GigaGen gathers up to $135M BARDA bucks to beat botulism

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own technician ...

GPCR company Septerna apply for IPO on toughness of preclinical data

.Septerna will learn just how a biotech without "any type of purposeful scientific data" meals in th...

Kurma shuts to begin with $154M haul for most significant biotech fund yet

.International VC company Kurma Allies has actually unveiled its newest biotech fund, along with 140...

Prothena ensures one officer while an additional leaves-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and al...

Editas capitalize Tip Cas9 licensing liberties for $57M

.Versus the background of a Cas9 license fight that rejects to pass away, Editas Medication is money...

Ultragenyx modifies genetics therapy dosing to dial up efficacy

.A minority of people taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have actually g...

Biopharma layoff price maintains in Q3: Brutal Biotech study

.As summer season heat counts on cool winds, really hopes that this year would take prevalent field ...

J &amp J drops stage 2 dengue prospect in most recent change coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious illness pipeline has asserted another...